Managua

A study conducted by OSI Pharmaceuticals Inc. of Melville and its partners in an anti-lung cancer drug, Tarceva indicates that the medication slows the advance of lung cancer when it is administered after chemotherapy.

On the other hand, another study has found that a combination of Avastin and Tarceva were ineffective in prolonging the life of cancer patients. 

The results of the study by OSI executives will be submitted at an upcoming medical conference. Thereafter they would be submitted to the US FDA for approval of Tarveca.

Intel Corp. is planning to step into health care business. The company would be providing technology to aid homebound chronic patients. 

Called as Health Guide, it is a small tabletop gadget to be manufactured by Intel. 

The device about the size of a small-form-factor P. Health Guide PHS6000 is a small white box with a flip-up 10.4-inch LCD touchscreen and a webcam with privacy shield. It hosts an undisclosed Intel processor and motherboard. The device is equipped with Bluetooth and four USB ports.

A rare print of New York - The United Nations headquarters prepares to lock down one more time this year when the kings of Saudi Arabia and Jordan, and US President George W Bush and Israeli President Shimon Peres attend a two-day conference on religion and peace, it was announced Monday.

Close to 70 government delegations will meet Wednesday and Thursday in the UN General Assembly for the "promotion of inter-religious and inter-cultural dialogue, understanding and cooperation of peace."

Frankfurt - Italian author Claudio Magris, 69, on Monday received a top German award for ideas.

The 20,000-euro (26,000-dollar) Walter Hallstein Prize was presented in the city of Frankfurt.

"My dream is of a European state," said Magris. He said the important problems could no longer be solved at national level.

Joschka Fischer, a former German foreign minister, eulogized Magris at the ceremony as "a great European intellectual."

Barcelona - Spain's Rafael Nadal, world number one, stepped down from the Davis Cup final against Argentina later this month, due to a knee injury.

Nadal himself explained his decision Monday in Barcelona, after undergoing several medical tests.

"I did everything I could to try to get to that final. I am used to playing on court with pain and I have stood it quite well. But this is a different kind of pain, a new pain. I cannot manage to control it," the tennis player said.